Dutasteride

Details

Files

Generic Name:

Dutasteride

Project Status:

Complete

Therapeutic Area:

Prostatic hyperplasia, benign

Manufacturer:

GlaxoSmithKline Inc.

Brand Name:

Avodart

Project Line:

Reimbursement Review

Project Number:

SR0019-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Prostatic hyperplasia, benign

Recommendation Type:

List in a similar manner to other drugs in class

Final Recommendation:

January 20, 2005

Recommendation:

List in a similar manner as drug plans list finasteride for treatment of benign prostatic hyperplasia in men with an enlarged prostate

Last Updated : August 24, 2004